Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
Molecular Medicine (Cambridge, Mass.)
|
December 30, 2025
CSF metabolomic signature during therapy for childhood acute lymphoblastic leukemia predicts subsequent working memory impairment
Jeremy Willekens, Sameera Ramjan, Stephen A Sands, et al.
JAMA Network Open
|
May 14, 2025
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia
Elena J Ladas, Haiyang Sheng, Uma H Athale, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
June 20, 2016
Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study
Elena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
January 15, 2019
Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort
Elena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Journal of the National Cancer Institute
|
June 1, 2023
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia
Puja J Umaretiya, Victoria B Koch, Yael Flamand, et al.
Blood
|
December 23, 2022
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults
Paul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc, et al.
Blood Advances
|
March 19, 2024
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis
Julia Driessen, Fer de Wit, Alex F Herrera, et al.
Pediatric Blood & Cancer
|
September 7, 2022
Feasibility of oncology clinical trial-embedded evaluation of social determinants of health
Rahela Aziz-Bose, Daniel J Zheng, Puja J Umaretiya, et al.
JAMA Oncology
|
January 2, 2025
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial
Stephen Daw, Peter D Cole, Bradford S Hoppe, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
Molecular Medicine (Cambridge, Mass.)
|
December 30, 2025
CSF metabolomic signature during therapy for childhood acute lymphoblastic leukemia predicts subsequent working memory impairment
Jeremy Willekens, Sameera Ramjan, Stephen A Sands, et al.
JAMA Network Open
|
May 14, 2025
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia
Elena J Ladas, Haiyang Sheng, Uma H Athale, et al.
Nutrition (Burbank, Los Angeles County, Calif.)
|
June 20, 2016
Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort study
Elena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2015
Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation
Miguel-Angel Perales, Izaskun Ceberio, Philippe Armand, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
January 15, 2019
Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort
Elena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Journal of the National Cancer Institute
|
June 1, 2023
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia
Puja J Umaretiya, Victoria B Koch, Yael Flamand, et al.
Blood
|
December 23, 2022
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults
Paul Harker-Murray, Christine Mauz-Körholz, Thierry Leblanc, et al.
Blood Advances
|
March 19, 2024
Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: a propensity score-matched analysis
Julia Driessen, Fer de Wit, Alex F Herrera, et al.
Pediatric Blood & Cancer
|
September 7, 2022
Feasibility of oncology clinical trial-embedded evaluation of social determinants of health
Rahela Aziz-Bose, Daniel J Zheng, Puja J Umaretiya, et al.
JAMA Oncology
|
January 2, 2025
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults: A Nonrandomized Clinical Trial
Stephen Daw, Peter D Cole, Bradford S Hoppe, et al.
Page
of 11